These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17049585)

  • 21. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
    Kotajima N; Kanda T; Fukumura Y; Kobayashi I
    J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of Xuebijing injection on thrombomodulin and endothelial cell protein C receptor in septic rats].
    Li YP; Qiao YJ; Wu ZX; Qian FF; Yao YM; Yu Y; Wu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):365-8. PubMed ID: 17577447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
    Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of the serum level of soluble E-cadherin in patients with HCC.
    Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of soluble thrombomodulin in the coronary circulation of patients with coronary artery disease].
    Nakagawa I; Matsubara T; Hori T; Imai S; Ozaki K; Mezaki T; Nasuno A; Kubota K; Nakano M; Yamazoe M; Aizawa Y
    J Cardiol; 2001 Sep; 38(3):145-52. PubMed ID: 11577611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma.
    Suehiro T; Shimada M; Matsumata T; Taketomi A; Yamamoto K; Sugimachi K
    Hepatology; 1995 May; 21(5):1285-90. PubMed ID: 7537712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma.
    Zhou J; Tang ZY; Fan J; Wu ZQ; Ji Y; Ye SL
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):559-64. PubMed ID: 11570577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?
    Saposnik B; Peynaud-Debayle E; Stepanian A; Baron G; Simansour M; Mandelbrot L; de Prost D; Gandrille S
    Thromb Res; 2012 Feb; 129(2):152-7. PubMed ID: 21824644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
    Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
    Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
    Cheng BQ; Jia CQ; Liu CT; Lu XF; Zhong N; Zhang ZL; Fan W; Li YQ
    Dig Liver Dis; 2008 Jun; 40(6):446-52. PubMed ID: 18294942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.